Liver Cancer | Tumor

CURE’s liver cancer page features the latest cancer news and updates on liver cancer Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in liver cancer.

‘Landmark’ FDA Approval of Tibsovo May Improve Outcomes for Liver Cancer Subtype

September 3rd 2021, 9:00pm


The FDA approval of Tibsovo marks the first targeted therapy for patients with this liver cancer subtype.

Tibsovo For The Treatment of Liver Cancer Subtype Receives FDA Approval

August 25th 2021, 8:54pm


Tibsovo — which is the first targeted therapy approved for this patient population — improved survival in patients with a subtype of liver cancer.

Older Liver Cancer Survivors Are Less Informed About Life After Cancer

August 5th 2021, 1:00pm


The results, according to the study authors, demonstrate a need to better inform older patients during treatment about survivorship after liver cancer.

Opdivo Regimen Pulled for Liver Cancer Treatment

July 28th 2021, 11:00pm


Opdivo was granted an accelerated approval for patients with hepatocellular carcinoma, but the indication was pulled after follow-up data failed to show that the agent improved survival over another drug.

Researchers Discover a Culprit Behind Aggressive Liver Cancer

July 12th 2021, 3:00pm


Patients whose disease contained the osteopontin protein tended to have more aggressive liver cancer that did not respond to treatment.

COVID-19 Pandemic Had Significant Impact on Liver Cancer Screenings and Care

July 9th 2021, 9:00pm


Screening and diagnostic procedures for liver cancer as well as transplant programs and curative/palliative treatments were modified or delayed due to the COVID-19 pandemic, a new survey says.

Alcohol-Cancer Link Needs More Recognition

July 8th 2021, 1:00pm


Most people surveyed knew about the link between alcohol and liver cancer, but far fewer knew that drinking could increase breast cancer risk, too.

Two-Drug Combo Shows Modest Benefit in Biliary Tract Cancer

June 15th 2021, 9:00pm


Treatment with the combination of Stivarga and Bavencio was associated with minor anti-tumor activity in patients with advanced, heavily pretreated biliary tract solid tumors.

Onivyde Combo Improves Outcomes for Patients with Metastatic Liver Cancer

June 8th 2021, 8:00pm


Onivyde combined with a chemotherapy agent and a chemotherapy-protective drug should be used as a second-line treatment option in patients with metastatic liver cancer, according to an expert.

5 Recent Cancer Drug Approvals That Patients May Have Missed

June 3rd 2021, 1:00pm


The Food and Drug Administration has had a busy couple of weeks, approving several agents to treat a variety of cancers. Here are five recent approvals that patients with cancer may have missed.